This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
Clinical trial NCT03448419 · COMPLETED
Trial details
- NCT number
- NCT03448419
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-20
- Primary completion
- 2019-09-30
- Enrollment
- 312
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.